Aptamer-mediated inhibition of Mycobacterium tuberculosis polyphosphate kinase 2

Ka To Shum1, Eric Lik Hang Lui, Sybil Cheuk Ki Wong

  • 1Department of Biochemistry, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China.

Biochemistry
|March 9, 2011
PubMed

Insights

Researchers developed DNA aptamers to inhibit Mycobacterium tuberculosis PPK2, a key enzyme in bacterial survival. A G-quadruplex aptamer showed potent and selective inhibition, offering a potential therapeutic strategy against tuberculosis.

Area of Science:

  • Microbiology
  • Biochemistry
  • Molecular Biology

Background:

  • Inorganic polyphosphate (polyP) is crucial for bacterial persistence, stress response, and virulence.
  • Polyphosphate kinase (PPK) enzymes regulate intracellular polyP metabolism.
  • Inhibiting PPK offers a strategy to disrupt polyP-dependent processes in pathogens.

Purpose of the Study:

  • Biochemically characterize Mycobacterium tuberculosis (MTB) PPK2.
  • Develop DNA aptamers to inhibit MTB PPK2 activity.
  • Investigate the inhibitory mechanism and specificity of aptamers.

Main Methods:

  • Biochemical assays to determine enzyme kinetics and catalytic rates.
  • Gel filtration chromatography for protein complex analysis.
  • Isothermal titration calorimetry for binding affinity and thermodynamics.
  • Circular dichroism for aptamer secondary structure determination.
  • Enzyme inhibition assays (IC50 determination) and kinetic analysis.
  • Mutational analysis to identify critical aptamer motifs.

Main Results:

  • MTB PPK2 exhibits a high polyP-dependent phosphorylation rate.
  • MTB PPK2 exists as an octamer.
  • A G-quadruplex DNA aptamer selectively binds MTB PPK2 with high affinity (Kd = 870 nM).
  • The aptamer noncompetitively inhibits MTB PPK2 with an IC50 of 40 nM.
  • The G-quadruplex motif is essential for inhibition.
  • The aptamer shows cross-inhibition against Vibrio cholerae PPK2.

Conclusions:

  • DNA aptamers, particularly G-quadruplex structures, are effective inhibitors of MTB PPK2.
  • The developed aptamer demonstrates high selectivity and potency.
  • This aptamer represents a promising lead for developing novel anti-tubercular therapeutics targeting PPK2.

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...